OtherBasic Science Investigations
Pegylated Arg-Gly-Asp Peptide: 64Cu Labeling and PET Imaging of Brain Tumor αvβ3-Integrin Expression
Xiaoyuan Chen, Yingping Hou, Michel Tohme, Ryan Park, Vazgen Khankaldyyan, Ignacio Gonzales-Gomez, James R. Bading, Walter E. Laug and Peter S. Conti
Journal of Nuclear Medicine October 2004, 45 (10) 1776-1783;
Xiaoyuan Chen
Yingping Hou
Michel Tohme
Ryan Park
Vazgen Khankaldyyan
Ignacio Gonzales-Gomez
James R. Bading
Walter E. Laug
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Pegylated Arg-Gly-Asp Peptide: 64Cu Labeling and PET Imaging of Brain Tumor αvβ3-Integrin Expression
Xiaoyuan Chen, Yingping Hou, Michel Tohme, Ryan Park, Vazgen Khankaldyyan, Ignacio Gonzales-Gomez, James R. Bading, Walter E. Laug, Peter S. Conti
Journal of Nuclear Medicine Oct 2004, 45 (10) 1776-1783;
Pegylated Arg-Gly-Asp Peptide: 64Cu Labeling and PET Imaging of Brain Tumor αvβ3-Integrin Expression
Xiaoyuan Chen, Yingping Hou, Michel Tohme, Ryan Park, Vazgen Khankaldyyan, Ignacio Gonzales-Gomez, James R. Bading, Walter E. Laug, Peter S. Conti
Journal of Nuclear Medicine Oct 2004, 45 (10) 1776-1783;
Related Articles
Cited By...
- A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1: Validation in Mouse Models and Human Cancer Tissues
- A Novel Engineered Anti-CD20 Tracer Enables Early Time PET Imaging in a Humanized Transgenic Mouse Model of B-cell Non-Hodgkins Lymphoma
- Novel 64Cu- and 68Ga-Labeled RGD Conjugates Show Improved PET Imaging of {alpha}{nu}{beta}3 Integrin Expression and Facile Radiosynthesis
- Imaging of {alpha}v{beta}3 Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with {alpha}v{beta}5
- A Novel Neutrophil-Specific PET Imaging Agent: cFLFLFK-PEG-64Cu
- 111In-LLP2A-DOTA Polyethylene Glycol-Targeting {alpha}4{beta}1 Integrin: Comparative Pharmacokinetics for Imaging and Therapy of Lymphoid Malignancies
- Engineered Knottin Peptides: A New Class of Agents for Imaging Integrin Expression in Living Subjects
- Identification and Characterization of a Peptide with Affinity to Head and Neck Cancer
- Multimodality Probes: Amphibian Cars for Molecular Imaging
- Multimodality Molecular Imaging of Tumor Angiogenesis
- Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature
- microPET of Tumor Integrin {alpha}v{beta}3 Expression Using 18F-Labeled PEGylated Tetrameric RGD Peptide (18F-FPRGD4)
- Small-Animal PET of Tumor Angiogenesis Using a 76Br-Labeled Human Recombinant Antibody Fragment to the ED-B Domain of Fibronectin
- Specific Targeting of Tumor Angiogenesis by RGD-Conjugated Ultrasmall Superparamagnetic Iron Oxide Particles Using a Clinical 1.5-T Magnetic Resonance Scanner
- PET Imaging of Colorectal Cancer in Xenograft-Bearing Mice by Use of an 18F-Labeled T84.66 Anti-Carcinoembryonic Antigen Diabody
- How molecular imaging is speeding up antiangiogenic drug development
- In vitro and In vivo Characterization of 64Cu-Labeled AbegrinTM, a Humanized Monoclonal Antibody against Integrin {alpha}v{beta}3
- Positron Emission Tomography As an Imaging Biomarker
- A Thiol-Reactive 18F-Labeling Agent, N-[2-(4-18F-Fluorobenzamido)Ethyl]Maleimide, and Synthesis of RGD Peptide-Based Tracer for PET Imaging of {alpha}v{beta}3 Integrin Expression
- Characterization and Development of a Peptide (p160) with Affinity for Neuroblastoma Cells
- Molecular Targeting with Peptides or Peptide-Polymer Conjugates: Just a Question of Size?
- microPET Imaging of Glioma Integrin {alpha}v{beta}3 Expression Using 64Cu-Labeled Tetrameric RGD Peptide
- Preclinical Evaluation of the Breast Cancer Cell-Binding Peptide, p160